Immune mechanisms of intraocular inflammation

References

• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am. J. Ophthalmol.140(3), 509–516 (2005).
   PubMed Web of Science ®Google Scholar
• Deschenes J, Murray PI, Rao NA, Nussenblatt RB. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul. Immunol. Inflamm.16(1), 1–2 (2008).
   PubMed Web of Science ®Google Scholar
• Dick AD. Immune mechanisms of uveitis: insights into disease pathogenesis and treatment. Int. Ophthalmol. Clin.40(2), 1–18 (2000).
   PubMedGoogle Scholar
• Lowder CY, Char DH. Uveitis. A review. West J. Med.140(3), 421–432 (1984).
   PubMedGoogle Scholar
• Imrie FR, Dick AD. Biologics in the treatment of uveitis. Curr. Opin. Ophthalmol.18(6), 481–486 (2007).
   PubMed Web of Science ®Google Scholar
• Imrie FR, Dick AD. Nonsteroidal drugs for the treatment of noninfectious posterior and intermediate uveitis. Curr. Opin. Ophthalmol.18(3), 212–219 (2007).
   PubMed Web of Science ®Google Scholar
• Teoh SC, Hogan AC, Dick AD, Lee RW. Mycophenolate mofetil for the treatment of uveitis. Am. J. Ophthalmol.146(5), 752–760, 760.e1–3 (2008).
   PubMed Web of Science ®Google Scholar
• Hogan AC, McAvoy CE, Dick AD, Lee RW. Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis. Ophthalmology114(5), 1000–1006 (2007).
   PubMed Web of Science ®Google Scholar
• Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica218(4), 223–236 (2004).
   PubMed Web of Science ®Google Scholar
• Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology111(3), 491–500; discussion 500 (2004).
   PubMed Web of Science ®Google Scholar
• Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br. J. Ophthalmol.80(9), 844–848 (1996).
   PubMed Web of Science ®Google Scholar
• Chiang YP, Bassi LJ, Javitt JC. Federal budgetary costs of blindness. Milbank Q.70(2), 319–340 (1992).
   PubMed Web of Science ®Google Scholar
• Forrester JV. Intermediate and posterior uveitis. Chem. Immunol. Allergy92, 228–243 (2007).
   PubMedGoogle Scholar
• Wacker WB, Lipton MM. Experimental allergic uveitis: homologous retina as uveitogenic antigen. Nature206(981), 253–254 (1965).
   PubMed Web of Science ®Google Scholar
• Wacker WB, Donoso LA, Kalsow CM, Yankeelov JA Jr, Organisciak DT. Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina. J. Immunol.119(6), 1949–1958 (1977).
   PubMed Web of Science ®Google Scholar
• Thurau SR, Chan CC, Nussenblatt RB, Caspi RR. Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals. Clin. Exp. Immunol.109(2), 370–376 (1997).
   PubMed Web of Science ®Google Scholar
• Laliotou B, Liversidge J, Forrester JV, Dick AD. Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific. Br. J. Ophthalmol.81(1), 61–67 (1997).
   PubMedGoogle Scholar
• Paques M, Guyomard J-L, Simonutti M et al. Panretinal, high-resolution color photography of the mouse fundus. Invest. Ophthalmol. Vis. Sci.48(6), 2769–2774 (2007).
   PubMedGoogle Scholar
• Copland DA, Wertheim MS, Armitage WJ et al. The clinical time-course of experimental autoimmune uveoretinitis using topical endoscopic fundal imaging with histologic and cellular infiltrate correlation. Invest. Ophthalmol. Vis. Sci.49(12), 5458–5465 (2008).
   PubMed Web of Science ®Google Scholar
• de Smet MD, Yamamoto JH, Mochizuki M et al. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am. J. Ophthalmol.110(2), 135–142 (1990).
   PubMed Web of Science ®Google Scholar
• Saxena S, Rajasingh J, Biswas S et al. Cellular immune response to retinal S-antigen and interphotoreceptor retinoid-binding protein fragments in Eales’ disease patients. Pathobiology67(1), 39–44 (1999).
   PubMedGoogle Scholar
• Yamamoto JH, Minami M, Inaba G, Masuda K, Mochizuki M. Cellular autoimmunity to retinal specific antigens in patients with Behcet’s disease. Br. J. Ophthalmol.77(9), 584–589 (1993).
   PubMed Web of Science ®Google Scholar
• Szpak Y, Vieville J-C, Tabary T et al. Spontaneous retinopathy in HLA-A29 transgenic mice. Proc. Natl Acad. Sci. USA98(5), 2572–2576 (2001).
   PubMed Web of Science ®Google Scholar
• Pennesi G, Mattapallil MJ, Sun SH et al. A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J. Clin. Invest.111(8), 1171–1180 (2003).
   PubMed Web of Science ®Google Scholar
• Stein-Streilein J, Streilein JW. Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int. Rev. Immunol.21(2), 123–152 (2002).
   PubMedGoogle Scholar
• Medawar PB. A second study of the behaviour and fate of skin homografts in rabbits: a report to the War Wounds Committee of the Medical Research Council. J. Anat.79(Pt 4), 157–176.4 (1945).
   Web of Science ®Google Scholar
• Medawar PB. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol.29(1), 58–69 (1948).
   PubMed Web of Science ®Google Scholar
• Forrester JV. Privilege revisited: an evaluation of the eye’s defence mechanisms. Eye23(4), 756–766 (2009).
   PubMedGoogle Scholar
• Goldmann J, Kwidzinski E, Brandt C et al. T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa. J. Leukoc. Biol.80(4), 797–801 (2006).
   PubMed Web of Science ®Google Scholar
• Plsková J, Holán V, Filipec M, Forrester JV. Lymph node removal enhances corneal graft survival in mice at high risk of rejection. BMC Ophthalmol.4(1), 3 (2004).
   PubMedGoogle Scholar
• Camelo S, Kezic J, Shanley A, Rigby P, McMenamin PG. Antigen from the anterior chamber of the eye travels in a soluble form to secondary lymphoid organs via lymphatic and vascular routes. Invest. Ophthalmol. Vis. Sci.47(3), 1039–1046 (2006).
   PubMedGoogle Scholar
• Simard AR, Rivest S. Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J.18(9), 998–1000 (2004).
   PubMed Web of Science ®Google Scholar
• Heping X, Mei C, Eric JM, John VF, Andrew DD. Turnover of resident retinal microglia in the normal adult mouse. Glia55(11), 1189–1198 (2007).
   PubMedGoogle Scholar
• Xu H, Manivannan A, Liversidge J et al. Requirements for passage of T lymphocytes across non-inflamed retinal microvessels. J. Neuroimmunol.142(1–2), 47–57 (2003).
   PubMed Web of Science ®Google Scholar
• Kerr EC, Raveney BJE, Copland DA, Dick AD, Nicholson LB. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. J. Autoimmun.31(4), 354–361 (2008).
   PubMed Web of Science ®Google Scholar
• Zeevi A, Girnita A, Duquesnoy R. HLA antibody analysis. Immunol. Res.36(1), 255–264 (2006).
   PubMed Web of Science ®Google Scholar
• Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express Ia antigens. Nature282(5736), 326–327 (1979).
   PubMed Web of Science ®Google Scholar
• Brissette-Storkus CS, Reynolds SM, Lepisto AJ, Hendricks RL. Identification of a novel macrophage population in the normal mouse corneal stroma. Invest. Ophthalmol. Vis. Sci.43(7), 2264–2271 (2002).
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Kuwabara T, de Monasterio FM, Wacker WB. S-antigen uveitis in primates. A new model for human disease. Arch. Ophthalmol.99(6), 1090–1092 (1981).
   PubMedGoogle Scholar
• Sosnova M, Bradl M, Forrester JV. CD34+ corneal stromal cells are bone marrow-derived and express hemopoietic stem cell markers. Stem Cells23(4), 507–515 (2005).
   PubMed Web of Science ®Google Scholar
• Kuffova L, Netukova M, Duncan L et al. Cross presentation of antigen on MHC class II via the draining lymph node after corneal transplantation in mice. J. Immunol.180(3), 1353–1361 (2008).
   PubMedGoogle Scholar
• Dick AD. Influence of microglia on retinal progenitor cell turnover and cell replacement. Eye23, 1939–1945 (2009).
   PubMedGoogle Scholar
• Nicholson LB, Raveney BJ, Munder M. Monocyte dependent regulation of autoimmune inflammation. Curr. Mol. Med.9(1), 23–29 (2009).
   PubMed Web of Science ®Google Scholar
• Taylor AW. Ocular immunosuppressive microenvironment. Chem. Immunol. Allergy92, 71–85 (2007).
   PubMedGoogle Scholar
• Niederkorn JY, Mayhew E. Role of splenic B cells in the immune privilege of the anterior chamber of the eye. Eur. J. Immunol.25(10), 2783–2787 (1995).
   PubMedGoogle Scholar
• Lin H-H, Faunce DE, Stacey M et al. The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J. Exp. Med.201(10), 1615–1625 (2005).
   PubMed Web of Science ®Google Scholar
• Sonoda K-H, Exley M, Snapper S, Balk SP, Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med.190(9), 1215–1226 (1999).
   PubMed Web of Science ®Google Scholar
• Ashour HM, Niederkorn JY. gd T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10. J. Immunol.177(12), 8331–8337 (2006).
   PubMed Web of Science ®Google Scholar
• Sonoda KH, Sakamoto T, Qiao H et al. The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation. Immunology116(3), 390–399 (2005).
   PubMed Web of Science ®Google Scholar
• Anand V, Duffy B, Yang Z et al. A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus. Mol. Ther.5(2), 125–132 (2002).
   PubMed Web of Science ®Google Scholar
• Banerjee S, Dick AD, Nicholls SM. Factors affecting rejection of second corneal transplants in rats. Transplantation77(4), 492–496 (2004).
   PubMedGoogle Scholar
• Charukamnoetkanok P, Fukushima A, Whitcup SM, Gery I, Egwuagu CE. Expression of ocular autoantigens in the mouse thymus. Curr. Eye Res.17(8), 788–792 (1998).
   PubMed Web of Science ®Google Scholar
• Egwuagu CE, Charukamnoetkanok P, Gery I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J. Immunol.159(7), 3109–3112 (1997).
   PubMed Web of Science ®Google Scholar
• Takase H, Yu CR, Mahdi RM et al. Thymic expression of peripheral tissue antigens in humans: a remarkable variability among individuals. Int. Immunol.17(8), 1131–1140 (2005).
   PubMedGoogle Scholar
• Avichezer D, Grajewski RS, Chan CC et al. An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J. Exp. Med.198(11), 1665–1676 (2003).
   PubMedGoogle Scholar
• Anderson MS, Venanzi ES, Klein L et al. Projection of an immunological self shadow within the thymus by the aire protein. Science298(5597), 1395–1401 (2002).
   PubMed Web of Science ®Google Scholar
• DeVoss J, Hou Y, Johannes K et al. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J. Exp. Med.203(12), 2727–2735 (2006).
   PubMed Web of Science ®Google Scholar
• de Smet MD, Bitar G, Mainigi S, Nussenblatt RB. Human S-antigen determinant recognition in uveitis. Invest. Ophthalmol. Vis. Sci.42(13), 3233–3238 (2001).
   PubMed Web of Science ®Google Scholar
• Rai G, Saxena S, Kumar H, Singh VK. Human retinal S-antigen: T cell epitope mapping in posterior uveitis patients. Exp. Mol. Pathol.70(2), 140–145 (2001).
   PubMedGoogle Scholar
• Tripathi P, Saxena S, Yadav VS, Naik S, Singh VK. Human S-antigen: peptide determinant recognition in uveitis patients. Exp. Mol. Pathol.76(2), 122–128 (2004).
   PubMedGoogle Scholar
• de Smet MD, Dayan M, Nussenblatt RB. A novel method for the determination of T-cell proliferative responses in patients with uveitis. Ocul. Immunol. Inflamm.6(3), 173–178 (1998).
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol.155(3), 1151–1164 (1995).
   PubMed Web of Science ®Google Scholar
• Nanke Y, Kotake S, Goto M et al. Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet’s disease before ocular attack: a possible predictive marker of ocular attack. Mod. Rheumatol.18(4), 354–358 (2008).
   PubMed Web of Science ®Google Scholar
• Yeh S, Li Z, Forooghian F et al. CD4+Foxp3+ T-regulatory cells in noninfectious uveitis. Arch. Ophthalmol.127(4), 407–413 (2009).
   PubMedGoogle Scholar
• Chen L, Yang P, Zhou H et al. Decreased frequency and diminished function of CD4+CD25high regulatory T cells are associated with active uveitis in patients with Vogt–Koyanagi–Harada syndrome. Invest. Ophthalmol. Vis. Sci.49(8), 3475–3482 (2008).
   PubMed Web of Science ®Google Scholar
• Keino H, Takeuchi M, Usui Y et al. Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis. Br. J. Ophthalmol.91(1), 105–110 (2007).
   PubMed Web of Science ®Google Scholar
• Grajewski RS, Silver PB, Agarwal RK et al. Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity. J. Exp. Med.203(4), 851–856 (2006).
   PubMed Web of Science ®Google Scholar
• Luger D, Caspi RR. New perspectives on effector mechanisms in uveitis. Semin. Immunopathol.30(2), 135–143 (2008).
   PubMed Web of Science ®Google Scholar
• Prendergast RA, Iliff CE, Coskuncan NM et al. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest. Ophthalmol. Vis. Sci.39(5), 754–762 (1998).
   PubMed Web of Science ®Google Scholar
• Thurau SR, Mempel TR, Flugel A et al. The fate of autoreactive, GFP+ T cells in rat models of uveitis analyzed by intravital fluorescence microscopy and FACS. Int. Immunol.16(11), 1573–1582 (2004).
   PubMedGoogle Scholar
• Su SB, Grajewski RS, Luger D et al. Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-γ deficiency. Invest. Ophthalmol. Vis. Sci.48(10), 4616–4625 (2007).
   PubMed Web of Science ®Google Scholar
• Forrester JV, Huitinga I, Lumsden L, Dijkstra CD. Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats. Curr. Eye Res.17(4), 426–437 (1998).
   PubMed Web of Science ®Google Scholar
• Kitaichi N, Kotake S, Morohashi T et al. Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells. J. Leukoc. Biol.72(6), 1117–1121 (2002).
   PubMed Web of Science ®Google Scholar
• Rizzo LV, Silver P, Wiggert B et al. Establishment and characterization of a murine CD4+ T cell line and clone that induce experimental autoimmune uveoretinitis in B10.A mice. J. Immunol.156(4), 1654–1660 (1996).
   PubMed Web of Science ®Google Scholar
• Carneiro LAM, Travassos LH, Girardin SE. Nod-like receptors in innate immunity and inflammatory diseases. Ann. Med.39(8), 581–593 (2007).
   PubMed Web of Science ®Google Scholar
• Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F. NOD2-associated diseases: bridging innate immunity and autoinflammation. Clin. Immunol. doi:10.1016/j.clim.2009.05.005 (2009) (Epub ahead of print).
   Google Scholar
• Chang JH, McCluskey PJ, Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br. J. Ophthalmol.90(1), 103–108 (2006).
   PubMed Web of Science ®Google Scholar
• Brito BE, Zamora DO, Bonnah RA et al. Toll-like receptor 4 and CD14 expression in human ciliary body and TLR-4 in human iris endothelial cells. Exp. Eye Res.79(2), 203–208 (2004).
   PubMed Web of Science ®Google Scholar
• Chang JH, McCluskey P, Wakefield D. Expression of Toll-like receptor 4 and its associated lipopolysaccharide receptor complex by resident antigen-presenting cells in the human uvea. Invest. Ophthalmol. Vis. Sci.45(6), 1871–1878 (2004).
   PubMed Web of Science ®Google Scholar
• Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv. Ophthalmol.50(4), 364–388 (2005).
   PubMed Web of Science ®Google Scholar
• Cho Y, Wang JJ, Chew EY et al. Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case–control samples. Invest. Ophthalmol. Vis. Sci.50, 5614–5618 (2009).
   PubMed Web of Science ®Google Scholar
• Jiang G, Ke Y, Sun D et al. Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes. Invest. Ophthalmol. Vis. Sci.50, 4769–4776 (2009).
   PubMed Web of Science ®Google Scholar
• Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1b generation. Clin. Exp. Immunol.147(2), 227–235 (2007).
   PubMed Web of Science ®Google Scholar
• Miceli-Richard C, Lesage S, Rybojad M et al.CARD15 mutations in Blau syndrome. Nat. Genet.29(1), 19–20 (2001).
   PubMed Web of Science ®Google Scholar
• Hugot J-P, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature411(6837), 599–603 (2001).
   PubMed Web of Science ®Google Scholar
• Rosenzweig HL, Martin TM, Jann MM et al.NOD2, the gene responsible for familial granulomatous uveitis, in a mouse model of uveitis. Invest. Ophthalmol. Vis. Sci.49(4), 1518–1524 (2008).
   PubMed Web of Science ®Google Scholar
• Rosenzweig HL, Martin TM, Planck SR et al. Activation of NOD2in vivo induces IL-1b production in the eye via caspase-1 but results in ocular inflammation independently of IL-1 signaling. J. Leukoc. Biol.84(2), 529–536 (2008).
   PubMedGoogle Scholar
• Rosenzweig HL, Kawaguchi T, Martin TM et al. Nucleotide oligomerization domain-2 (NOD2)-induced uveitis: dependence on IFN-γ. Invest. Ophthalmol. Vis. Sci.50(4), 1739–1745 (2009).
   PubMedGoogle Scholar
• Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol.12(1), 991–1045 (1994).
   PubMed Web of Science ®Google Scholar
• McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med.3(8), e297 (2006).
   PubMed Web of Science ®Google Scholar
• McDermott MF. Genetic clues to understanding periodic fevers, and possible therapies. Trends Mol. Med.8(12), 550–554 (2002).
   PubMedGoogle Scholar
• Lachmann HJ, Lowe P, Felix SD et al.In vivo regulation of interleuki 1b in patients with cryopyrin-associated periodic syndromes. J. Exp. Med.206(5), 1029–1036 (2009).
   PubMed Web of Science ®Google Scholar
• Lequerre T, Vittecoq O, Saugier-Veber P et al. A cryopyrin-associated periodic syndrome with joint destruction. Rheumatology46(4), 709–714 (2007).
   PubMed Web of Science ®Google Scholar
• Martin TM, Zhang Z, Kurz P et al. The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheum.60(2), 611–618 (2009).
   PubMedGoogle Scholar
• Arostegui JI, Arnal C, Merino R et al.NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum.56(11), 3805–3813 (2007).
   PubMed Web of Science ®Google Scholar
• Wang X-C, Norose K, Yano A, Ohta K, Segawa K. Two-color flow cytometric analysis of activated T lymphocytes in aqueous humor of patients with endogenous vs. exogenous uveitis. Curr. Eye Res.14(6), 425–433 (1995).
   PubMed Web of Science ®Google Scholar
• Calder VL, Zhao ZS, Wang Y, Barton K, Lightman SL. Effects of CD8 depletion on retinal soluble antigen induced experimental autoimmune uveoretinitis. Immunology79(2), 255–262 (1993).
   PubMed Web of Science ®Google Scholar
• McPherson SW, Yang J, Chan CC, Dou C, Gregerson DS. Resting CD8 T cells recognize β-galactosidase expressed in the immune-privileged retina and mediate autoimmune disease when activated. Immunology110(3), 386–396 (2003).
   PubMedGoogle Scholar
• Shao H, Peng Y, Liao T et al. A shared epitope of the interphotoreceptor retinoid-binding protein recognized by the CD4+ and CD8+ autoreactive T cells. J. Immunol.175(3), 1851–1857 (2005).
   PubMed Web of Science ®Google Scholar
• Norose K, Yano A, Aosai F, Segawa K. Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt–Koyanagi–Harada disease. Invest. Ophthalmol. Vis. Sci.31(7), 1210–1216 (1990).
   PubMed Web of Science ®Google Scholar
• Ohta K, Norose K, Wang X-C, Ito S, Yoshimura N. Abnormal naive and memory T lymphocyte subsets in the peripheral blood of patients with uveitis. Curr. Eye Res.16(7), 650–655 (1997).
   PubMed Web of Science ®Google Scholar
• Murphy CC, Duncan L, Forrester JV, Dick AD. Systemic CD4+ T cell phenotype and activation status in intermediate uveitis. Br. J. Ophthalmol.88(3), 412–416 (2004).
   PubMed Web of Science ®Google Scholar
• Ilhan F, Demir T, Turkcuoglu P et al. Th1 polarization of the immune response in uveitis in Behcet’s disease. Can. J. Ophthalmol.43(1), 105–108 (2008).
   PubMed Web of Science ®Google Scholar
• Imai Y, Sugita M, Nakamura S, Toriyama S, Ohno S. Cytokine production and helper T cell subsets in Vogt–Koyanagi–Harada’s disease. Curr. Eye Res.22(4), 312–318 (2001).
   PubMed Web of Science ®Google Scholar
• Li B, Yang P, Zhou H et al. Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt–Koyanagi–Harada disease. Br. J. Ophthalmol.89(11), 1410–1412 (2005).
   PubMed Web of Science ®Google Scholar
• Muhaya M, Calder V, Towler HM et al. Characterization of T cells and cytokines in the aqueous humour (AH) in patients with Fuchs’ heterochromic cyclitis (FHC) and idiopathic anterior uveitis (IAU). Clin. Exp. Immunol.111(1), 123–128 (1998).
   PubMed Web of Science ®Google Scholar
• Murray PI, Clay CD, Mappin C, Salmon M. Molecular analysis of resolving immune responses in uveitis. Clin. Exp. Immunol.117(3), 455–461 (1999).
   PubMed Web of Science ®Google Scholar
• Liu X, Yang P, Lin X et al. Inhibitory effect of cyclosporin A and corticosteroids on the production of IFN-γ and IL-17 by T cells in Vogt–Koyanagi–Harada syndrome. Clin. Immunol.131(2), 333–342 (2009).
   PubMed Web of Science ®Google Scholar
• Frassanito MA, Dammacco R, Fusaro T et al. Combined cyclosporin-A/prednisone therapy of patients with active uveitis suppresses IFN-γ production and the function of dendritic cells. Clin. Exp. Immunol.133(2), 233–239 (2003).
   PubMedGoogle Scholar
• Vignali DA. Multiplexed particle-based flow cytometric assays. J. Immunol. Methods243(1–2), 243–255 (2000).
   PubMed Web of Science ®Google Scholar
• Banerjee S, Savant V, Scott RA et al. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Invest. Ophthalmol. Vis. Sci.48(5), 2203–2207 (2007).
   PubMed Web of Science ®Google Scholar
• Curnow SJ, Falciani F, Durrani OM et al. Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest. Ophthalmol. Vis. Sci.46(11), 4251–4259 (2005).
   PubMed Web of Science ®Google Scholar
• Amadi-Obi A, Yu C-R, Liu X et al. Th17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med.13(6), 711–718 (2007).
   PubMed Web of Science ®Google Scholar
• Chi W, Yang P, Li B et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt–Koyanagi–Harada disease. J. Allergy Clin. Immunol.119(5), 1218–1224 (2007).
   PubMed Web of Science ®Google Scholar
• Chi W, Zhu X, Yang P et al. Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest. Ophthalmol. Vis. Sci.49(7), 3058–3064 (2008).
   PubMed Web of Science ®Google Scholar
• Szabo SJ, Kim ST, Costa GL et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell100(6), 655–669 (2000).
   PubMed Web of Science ®Google Scholar
• Zheng W-P, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell89(4), 587–596 (1997).
   PubMed Web of Science ®Google Scholar
• Jones LS, Rizzo LV, Agarwal RK et al. IFN-γ-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J. Immunol.158(12), 5997–6005 (1997).
   PubMed Web of Science ®Google Scholar
• Tarrant TK, Silver PB, Chan C-C, Wiggert B, Caspi RR. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. J. Immunol.161(1), 122–127 (1998).
   PubMedGoogle Scholar
• Tarrant TK, Silver PB, Wahlsten JL et al. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon g, nitric oxide, and apoptosis. J. Exp. Med.189(2), 219–230 (1999).
   PubMed Web of Science ®Google Scholar
• Becher B, Durell BG, Noelle RJ. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest.110(4), 493–497 (2002).
   PubMed Web of Science ®Google Scholar
• Oppmann B, Lesley R, Blom B et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity13(5), 715–725 (2000).
   PubMed Web of Science ®Google Scholar
• Cua DJ, Sherlock J, Chen Y et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature421(6924), 744–748 (2003).
   PubMed Web of Science ®Google Scholar
• Murphy CA, Langrish CL, Chen Y et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med.198(12), 1951–1957 (2003).
   PubMed Web of Science ®Google Scholar
• Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol.25(1), 821–852 (2007).
   PubMed Web of Science ®Google Scholar
• Ivanov II, McKenzie BS, Zhou L et al. The orphan nuclear receptor RORgt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell126(6), 1121–1133 (2006).
   PubMed Web of Science ®Google Scholar
• Manel N, Unutmaz D, Littman DR. The differentiation of human Th-17 cells requires transforming growth factor-b and induction of the nuclear receptor RORgt. Nat. Immunol.9(6), 641–649 (2008).
   PubMed Web of Science ®Google Scholar
• Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med.361(9), 888–898 (2009).
   PubMed Web of Science ®Google Scholar
• Yang XO, Pappu BP, Nurieva R et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORa and RORg. Immunity28(1), 29–39 (2008).
   PubMed Web of Science ®Google Scholar
• Yang L, Anderson DE, Baecher-Allan C et al. IL-21 and TGF-b are required for differentiation of human Th17 cells. Nature454(7202), 350–352 (2008).
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu. Rev. Immunol.27(1), 485–517 (2009).
   PubMed Web of Science ®Google Scholar
• Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med.201(2), 233–240 (2005).
   PubMed Web of Science ®Google Scholar
• Luger D, Silver PB, Tang J et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med.205(4), 799–810 (2008).
   PubMed Web of Science ®Google Scholar
• Kim SJ, Zhang M, Vistica BP et al. Induction of ocular inflammation by T-helper lymphocytes type 2. Invest. Ophthalmol. Vis. Sci.43(3), 758–765 (2002).
   PubMedGoogle Scholar
• Grajewski RS, Hansen AM, Agarwal RK et al. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-γ production and dampening of the adaptive Th1 and Th17 responses. J. Immunol.181(7), 4791–4797 (2008).
   PubMed Web of Science ®Google Scholar
• Pflanz S, Timans JC, Cheung J et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity16(6), 779–790 (2002).
   PubMed Web of Science ®Google Scholar
• Stumhofer JS, Laurence A, Wilson EH et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol.7(9), 937–945 (2006).
   PubMed Web of Science ®Google Scholar
• Batten M, Li J, Yi S et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol.7(9), 929–936 (2006).
   PubMed Web of Science ®Google Scholar
• Diveu C, McGeachy MJ, Boniface K et al. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J. Immunol.182(9), 5748–5756 (2009).
   PubMed Web of Science ®Google Scholar
• Sonobe Y, Yawata I, Kawanokuchi J et al. Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res.1040(1–2), 202–207 (2005).
   PubMed Web of Science ®Google Scholar
• Koenders MI, Lubberts E, Oppers-Walgreen B et al. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am. J. Pathol.167(1), 141–149 (2005).
   PubMed Web of Science ®Google Scholar
• Martine C, Pierre M. The combination of tumor necrosis factor a blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model. Arthritis Rheum.44(6), 1293–1303 (2001).
   PubMedGoogle Scholar
• Dick AD, Carter D, Robertson M et al. Control of myeloid activity during retinal inflammation. J. Leukoc. Biol.74(2), 161–166 (2003).
   PubMed Web of Science ®Google Scholar
• Calder CJ, Nicholson LB, Dick AD. A selective role for the TNF p55 receptor in autocrine signaling following IFN-γ stimulation in experimental autoimmune uveoretinitis. J. Immunol.175(10), 6286–6293 (2005).
   PubMed Web of Science ®Google Scholar
• Raveney BJE, Copland DA, Dick AD, Nicholson LB. TNFR1-dependent regulation of myeloid cell function in experimental autoimmune uveoretinitis. J. Immunol.183, 2321–2329 (2009).
   PubMed Web of Science ®Google Scholar
• Robertson M, Liversidge J, Forrester JV, Dick AD. Neutralizing tumor necrosis factor-a activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis. Invest. Ophthalmol. Vis. Sci.44(7), 3034–3041 (2003).
   PubMed Web of Science ®Google Scholar
• Murphy CC, Ayliffe WH, Booth A et al. Tumor necrosis factor a blockade with infliximab for refractory uveitis and scleritis. Ophthalmology111(2), 352–356 (2004).
   PubMed Web of Science ®Google Scholar
• Greiner K, Murphy CC, Willermain F et al. Anti-TNFα therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation. Invest. Ophthalmol. Vis. Sci.45(1), 170–176 (2004).
   PubMed Web of Science ®Google Scholar
• Broderick C, Hoek RM, Forrester JV et al. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am. J. Pathol.161(5), 1669–1677 (2002).
   PubMed Web of Science ®Google Scholar
• Copland DA, Calder CJ, Raveney BJE et al. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am. J. Pathol.171(2), 580–598 (2007).
   PubMed Web of Science ®Google Scholar
• Kos CH. Methods in nutrition science: Cre/loxP system for generating tissue-specific knockout mouse models. Nutr. Rev.62(6), 243–246 (2004).
   PubMedGoogle Scholar
• Mohammad DA, Sweet BV, Elner SG. Retisert: is the new advance in treatment of uveitis a good one? Ann. Pharmacother.41(3), 449–454 (2007).
   PubMed Web of Science ®Google Scholar
• Svenson S. Dendrimers as versatile platform in drug delivery applications. Eur. J. Pharm. Biopharm.71(3), 445–462 (2009).
   PubMed Web of Science ®Google Scholar
• Barker SE, Broderick CA, Robbie SJ et al. Subretinal delivery of adeno-associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent mice. J. Gene Med.11(6), 486–497 (2009).
   PubMed Web of Science ®Google Scholar
• Broderick CA, Smith AJ, Balaggan KS et al. Local administration of an adeno-associated viral vector expressing IL-10 reduces monocyte infiltration and subsequent photoreceptor damage during experimental autoimmune uveitis. Mol. Ther.12(2), 369–373 (2005).
   PubMed Web of Science ®Google Scholar
• Williams GJ, Brannan S, Forrester JV et al. The prevalence of sight-threatening uveitis in Scotland. Br. J. Ophthalmol.91(1), 33–36 (2007).
   PubMed Web of Science ®Google Scholar
• Jabs DA, Rosenbaum JT, Foster CS et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am. J. Ophthalmol.130(4), 492–513 (2000).
   PubMed Web of Science ®Google Scholar
• Howe LJ, Stanford MR, Edelsten C, Graham EM. The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis. Eye8(Pt 4) 443–447 (1994).
   PubMedGoogle Scholar
• Schewitz LP, Lee RW, Dayan CM, Dick AD. Glucocorticoids and the emerging importance of T cell subsets in steroid refractory diseases. Immunopharmacol. Immunotoxicol.31(1), 1–22 (2009).
   PubMed Web of Science ®Google Scholar
• Creed TJ, Lee RW, Newcomb PV et al. The effects of cytokines on suppression of lymphocyte proliferation by dexamethasone. J. Immunol.183(1), 164–171 (2009).
   PubMed Web of Science ®Google Scholar
• Lee RW, Creed TJ, Schewitz LP et al. CD4+CD25int T cells in inflammatory diseases refractory to treatment with glucocorticoids. J. Immunol.179(11), 7941–7948 (2007).
   PubMedGoogle Scholar
• Lee RW, Schewitz LP, Nicholson LB, Dayan CM, Dick AD. Steroid refractory CD4+ T cells in patients with sight-threatening uveitis. Invest. Ophthalmol. Vis. Sci.50, 4273–4278 (2009).
   PubMedGoogle Scholar
• Thurau SR, Wildner G. Oral tolerance for treating uveitis – new hope for an old immunological mechanism. Prog. Retin. Eye Res.21(6), 577–589 (2002).
   PubMedGoogle Scholar
• Ludvigsson J, Faresjo M, Hjorth M et al. GAD treatment and insulin secretion in recent-onset Type 1 diabetes. N. Engl. J. Med.359(18), 1909–1920 (2008).
   PubMed Web of Science ®Google Scholar
• Bar-Or A, Vollmer T, Antel J et al. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled Phase 1/2 trial. Arch. Neurol.64(10), 1407–1415 (2007).
   PubMed Web of Science ®Google Scholar
• Faria AM, Weiner HL. Oral tolerance: therapeutic implications for autoimmune diseases. Clin. Dev Immunol.13(2–4), 143–157 (2006).
   PubMed Web of Science ®Google Scholar
• Sanui H, Redmond TM, Kotake S et al. Uveitis and immune responses in primates immunized with IRBP-derived synthetic peptides. Curr. Eye Research9(2), 193–199 (1990).
   PubMed Web of Science ®Google Scholar
• Chan C-C, Nussenblatt RB, Wiggert B et al. Immunohistochemical analysis of experimental autoimmune uveoretinitis (Eau) induced by interphotoreceptor retinoid-binding protein(Irbp) in the rat. Immunol. Invest.16(1), 63–74 (1987).
   PubMed Web of Science ®Google Scholar
• Caspi RR, Chan CC, Leake WC et al. Experimental autoimmune uveoretinitis in mice. Induction by a single eliciting event and dependence on quantitative parameters of immunization. J. Autoimmun.3(3), 237–246 (1990).
   PubMed Web of Science ®Google Scholar
• Wacker WB,Dodd MC. The immunologic response of rabbits to homologous and heterologous corneal and uveal tissue. J. Immunol.86(6), 690–703 (1961).
   PubMedGoogle Scholar
• de Kozak Y, Sakai J, Thillaye B,Faure JP. S antigen-induced experimental autoimmune uveo-retinitis in rats. Curr. Eye Research1(6), 327–337 (1981).
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Kuwabara T, de Monasterio FM, Wacker WB. S-Antigen uveitis in primates: a new model for human disease. Arch. Ophthalmol.99(6), 1090–1092 (1981).
   PubMedGoogle Scholar
• Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR. Endotoxin-induced uveitis in rats as a model for human disease. Nature286(5773), 611–613 (1980).
   PubMed Web of Science ®Google Scholar
• Lai JC, Fukushima A, Wawrousek EF et al. Immunotolerance against a foreign antigen transgenically expressed in the lens. Invest. Ophthalmol. Vis. Sci.39(11), 2049–2057 (1998).
   PubMed Web of Science ®Google Scholar
• Lambe T, Leung JCH, Bouriez-Jones T et al. CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon fas–fas ligand interactions. J. Immunol.177(5), 3055–3062 (2006).
   PubMed Web of Science ®Google Scholar
• Schalken JJ, van Vugt AH, Winkens HJ et al. Experimental autoimmune uveoretinitis in rats induced by rod visual pigment: rhodopsin is more pathogenic than opsin. Graefes Arch. Clin. Exp. Ophthalmol.226(3), 255–261 (1988).
   PubMed Web of Science ®Google Scholar
• Ham D-I, Fujimoto C, Gentleman S et al. The level of thymic expression of RPE65 inversely correlates with its capacity to induce experimental autoimmune uveitis (EAU) in different rodent strains. Exp. Eye Res.83(4), 897–902 (2006).
   PubMedGoogle Scholar
• Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt–Koyanagi–Harada disease. J. Immunol.165(12), 7323–7329 (2000).
   PubMed Web of Science ®Google Scholar
• Bora NS, Sohn J-H, Kang S-G et al. Type I collagen is the autoantigen in experimental autoimmune anterior uveitis. J. Immunol.172(11), 7086–7094 (2004).
   PubMed Web of Science ®Google Scholar
• Broekhuyse RM, Kuhlmann ED, Winkens HJ. Experimental melanin-protein induced uveitis (EMIU) is the sole type of uveitis evoked by a diversity of ocular melanin preparations and melanin-derived soluble polypeptides. Jpn. J. Ophthalmol.40(4), 459–468 (1996).
   PubMed Web of Science ®Google Scholar